-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 HXrx99Xlic8jhmvC6+S4jvtjHRNA0EXwxrNL4hmxCjs+xxHJ79g6o3PYzQ9VeEZQ
 x82teXOB9iu2Zi/69zuJgg==

<SEC-DOCUMENT>9999999995-07-000035.txt : 20070104
<SEC-HEADER>9999999995-07-000035.hdr.sgml : 20070104
<ACCEPTANCE-DATETIME>20070104001518
ACCESSION NUMBER:		9999999995-07-000035
CONFORMED SUBMISSION TYPE:	EFFECT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20070103
DATE AS OF CHANGE:		20070104
EFFECTIVENESS DATE:		20070103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IMMUNOSYN CORP
		CENTRAL INDEX KEY:			0001375623
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		EFFECT
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-137881
		FILM NUMBER:		07506954

	BUSINESS ADDRESS:	
		STREET 1:		4225 EXECUTIVE SQUARE SUITE 260
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		858-200-2320

	MAIL ADDRESS:	
		STREET 1:		4225 EXECUTIVE SQUARE SUITE 260
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
</SEC-HEADER>
<DOCUMENT>
<TYPE>EFFECT
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<edgarSubmission>

    <schemaVersion>X0101</schemaVersion>

    <submissionType>EFFECT</submissionType>

    <act>33</act>

    <testOrLive>LIVE</testOrLive>

    <effectiveData>
        <finalEffectivenessDispDate>2007-01-03</finalEffectivenessDispDate>
        <finalEffectivenessDispTime>17:00:00</finalEffectivenessDispTime>
        <form>SB-2</form>
        <filer>
            <cik>0001375623</cik>
            <entityName>IMMUNOSYN CORP</entityName>
            <fileNumber>333-137881</fileNumber>
        </filer>
    </effectiveData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----